Effects of adrenal ablation on blood pressure and target organ damage in deoxycorticosterone acetate–salt hypertensive rats
Journal of International Medical Research · 2026-07 · 54 (7)
DOI: 10.1177/03000605261464286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of International Medical Research, online erschienen am 01.07.2026. Verfasst von Jindong Wan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, School of Clinical Medicine, The First Affiliated Hospital of Chengdu Medical College, China. Hauptthemen laut MEDLINE: Hypertension, Blood Pressure, Adrenalectomy, Adrenal Glands. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Primary aldosteronism is a common and underdiagnosed form of secondary hypertension. However, preclinical investigations of adrenal ablation as a potential therapeutic approach for primary aldosteronism treatment are limited.
Methods
A deoxycorticosterone acetate–salt hypertensive rat model was established, and the animals were treated with either unilateral adrenal ablation or oral spironolactone for 12 weeks. Blood pressure was continuously monitored throughout the study period. The key endpoints included blood pressure regulation, circulating hormone levels, and target organ damage.
Results
Adrenal ablation markedly reduced blood pressure in deoxycorticosterone acetate–salt hypertensive rats. During the first 8 weeks of treatment, the antihypertensive effect exerted by adrenal ablation was significantly greater than that achieved using oral spironolactone. After 8 weeks, the blood pressure–lowering effects of both interventions were comparable, although each effect remained significantly lower than that in the untreated controls. Moreover, adrenal ablation was more effective than spironolactone in attenuating the target organ damage associated with deoxycorticosterone acetate–salt hypertension.
Conclusions
Compared with oral spironolactone, adrenal ablation significantly lowered blood pressure and more effectively attenuated target organ damage in deoxycorticosterone acetate–salt hypertensive rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, School of Clinical Medicine, The First Affiliated Hospital of Chengdu Medical College, China.
- Clinical Research Center for Geriatrics of Sichuan Province, China.
- Key Laboratory of Aging and Vascular Homeostasis at Chengdu Medical College of Sichuan Province, China.
- School of Clinical Medicine, Chengdu Medical College, China.
ORCID-Profile: Jindong Wan, Peijian Wang
Zitieren
APA
Wan, J., Luo, T., Duan, R., Wang, X., Yang, Q., Hou, J., Wang, Y., Lv, Y., Ran, Q., Liu, S., & Wang, P. (2026). Effects of adrenal ablation on blood pressure and target organ damage in deoxycorticosterone acetate–salt hypertensive rats. Journal of International Medical Research, 54(7). https://doi.org/10.1177/03000605261464286
Vancouver
Wan J, Luo T, Duan R, Wang X, Yang Q, Hou J, et al. Effects of adrenal ablation on blood pressure and target organ damage in deoxycorticosterone acetate–salt hypertensive rats. Journal of International Medical Research. 2026;54(7). doi:10.1177/03000605261464286
BibTeX
@article{Wan2026,
author = {Wan, Jindong and Luo, Tao and Duan, Ruixue and Wang, Xinquan and Yang, Qianwei and Hou, Jixin and Wang, Yidan and Lv, Yuhang and Ran, Qianyue and Liu, Sen and Wang, Peijian},
title = {Effects of adrenal ablation on blood pressure and target organ damage in deoxycorticosterone acetate–salt hypertensive rats},
journal = {Journal of International Medical Research},
year = {2026},
volume = {54},
number = {7},
doi = {10.1177/03000605261464286}
}
EUVIMED